Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD52 | P43351 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | LGMN | Q99538 | 2/20 | 0.40 |
| ▸ | ACACB | O00763 | 3/20 | 0.39 |
| ▸ | DPP4 | P27487 | 7/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.33 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9715198 | 0.87 | GAA (0.50) | RAD52GAALGMNACACBDPP4 | |
| SCHEMBL3253263 | 0.86 | RAD52 (0.46) | RAD52GAALGMNACACBDPP4 | |
| SCHEMBL2127854 | 0.84 | RAD52 (0.44) | RAD52GAALGMNACACBDPP4 | |
| SCHEMBL5837740 | 0.83 | GAA (0.46) | RAD52GAALGMNACACBKDM4E | |
| Hydrochloric Acid SCHEMBL2532139 | 0.83 | RAD52 (0.43) | RAD52GAALGMNACACBDPP4 | |
| SCHEMBL13943920 | 0.82 | RAD52 (0.42) | RAD52GAALGMNACACBDPP4 | |
| SCHEMBL5836844 | 0.82 | GAA (0.48) | RAD52GAALGMNACACBKDM4E | |
| SCHEMBL5836652 | 0.82 | GAA (0.45) | RAD52GAALGMNACACBKDM4E | |
| SCHEMBL6838886 | 0.81 | MAPT (0.40) | RAD52GAAACACBKDM4EMAPT | |
| SCHEMBL3639807 | 0.81 | GAA (0.44) | RAD52GAALGMNKDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040250356-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a particular pearlescent or opacifying agent, methods and uses | L'OREAL (FR) | 2004-12-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040250356-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a particular pearlescent or opacifying agent, methods and uses | KRT18, CDC73, PPHLN1 | RAD52 457/4885GAA 4764/4885LGMN 2520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.